"Nephroureterectomy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Surgical removal of a kidney and adjoining ureter.
Descriptor ID |
D000074682
|
MeSH Number(s) |
E04.950.774.435.500
|
Concept/Terms |
Nephroureterectomy- Nephroureterectomy
- Nephroureterectomies
- Nephro-ureterectomy
- Nephro ureterectomy
- Nephro-ureterectomies
- Ureteronephrectomy
- Ureteronephrectomies
|
Below are MeSH descriptors whose meaning is more general than "Nephroureterectomy".
Below are MeSH descriptors whose meaning is more specific than "Nephroureterectomy".
This graph shows the total number of publications written about "Nephroureterectomy" by people in this website by year, and whether "Nephroureterectomy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2016 | 1 | 0 | 1 |
2017 | 2 | 4 | 6 |
2018 | 2 | 2 | 4 |
2019 | 3 | 0 | 3 |
2020 | 1 | 1 | 2 |
2021 | 2 | 1 | 3 |
2022 | 0 | 1 | 1 |
2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Nephroureterectomy" by people in Profiles.
-
Optimizing Lymph Node Dissection at the Time of Nephroureterectomy for High-risk Upper Tract Urothelial Carcinoma. Eur Urol Focus. 2023 03; 9(2):280-282.
-
Longitudinal GFR trends after neoadjuvant chemotherapy prior to nephroureterectomy for upper tract urothelial carcinoma. Urol Oncol. 2022 10; 40(10):454.e17-454.e23.
-
Predictive model for systemic recurrence following cisplatin-based neoadjuvant chemotherapy and radical nephroureterectomy for high risk upper tract urothelial carcinoma. Urol Oncol. 2021 11; 39(11):788.e15-788.e21.
-
The Impact of Upper Tract Urothelial Carcinoma Diagnostic Modality on Intravesical Recurrence after Radical Nephroureterectomy: A Single Institution Series and Updated Meta-analysis. Reply. J Urol. 2021 10; 206(4):1072.
-
The Impact of Upper Tract Urothelial Carcinoma Diagnostic Modality on Intravesical Recurrence after Radical Nephroureterectomy: A Single Institution Series and Updated Meta-Analysis. J Urol. 2021 Sep; 206(3):558-567.
-
Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinoma. BJU Int. 2021 05; 127(5):528-537.
-
Intraoperative prophylactic intravesical chemotherapy to reduce bladder recurrence following radical nephroureterectomy. Urol Oncol. 2020 09; 38(9):737.e11-737.e16.
-
PTRF independently predicts progression and survival in multiracial upper tract urothelial carcinoma following radical nephroureterectomy. Urol Oncol. 2020 05; 38(5):496-505.
-
Phase II Trial of Neoadjuvant Systemic Chemotherapy Followed by Extirpative Surgery in Patients with High Grade Upper Tract Urothelial Carcinoma. J Urol. 2020 04; 203(4):690-698.
-
Preoperative predictive model and nomogram for disease recurrence following radical nephroureterectomy for high grade upper tract urothelial carcinoma. Urol Oncol. 2019 10; 37(10):758-764.